This inventor holds 2 USPTO granted patents. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2001-2003.
Company Filing History:
Years Active: 2001-2003
Title: Innovations by Ursula Grohman in Regulating IL-10
Introduction
Ursula Grohman is a notable inventor based in Perugia, Italy. She has made significant contributions to the field of immunology, particularly in the regulation of interleukin-10 (IL-10) through the use of interleukin-9 (IL-9). With a total of 2 patents, her work has implications for treating various medical conditions.
Latest Patents
One of her latest patents is titled "Method for regulating IL-10 with IL-9, and applications thereof." This invention recognizes IL-9 as a crucial molecule involved in the induction of IL-10. The administration of IL-9 provides protection against conditions where IL-10 production is necessary, such as infections caused by Gram-negative bacteria. Conditions like septic shock and endotoxemia are highlighted as examples where this method can be beneficial. Additionally, the invention includes treatment methods where IL-9 and a phosphodiesterase inhibitor are administered to a subject. Compositions, including kits that contain these two components, are also part of the invention. Furthermore, the treatment of conditions involving excess IL-10 production can be achieved by administering an IL-9 inhibitor.
Career Highlights
Ursula Grohman is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her research and development in immunological therapies. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from severe infections and inflammatory conditions.
Collaborations
Ursula collaborates with Jacques Van Snick, a fellow researcher in the field. Their combined expertise contributes to advancing the understanding and treatment of immune-related conditions.
Conclusion
Ursula Grohman’s innovative work in regulating IL-10 through IL-9 showcases her significant contributions to medical research. Her patents reflect a commitment to developing effective treatments for critical health issues.